Agios Pharmaceuticals
AGIO
#5284
Rank
NZ$2.69 B
Marketcap
NZ$45.27
Share price
-0.85%
Change (1 day)
-5.05%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2025 (TTM): -NZ$0.81 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are NZ$54.02 Million. a decrease over its 2024 earnings that were of -NZ$0.72 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$0.8 Billion10.9%
2024 -NZ$0.72 Billion8.75%
2023 -NZ$0.66 Billion0.63%
2022 -NZ$0.66 Billion2.81%
2021 -NZ$0.64 Billion10.58%
2020 -NZ$0.58 Billion-18.41%
2019 -NZ$0.71 Billion15.72%
2018 -NZ$0.61 Billion12.99%
2017 -NZ$0.54 Billion59.61%
2016 -NZ$0.34 Billion69.32%
2015 -NZ$0.2 Billion119.28%
2014 -NZ$90.83 Million39.22%
2013 -NZ$65.25 Million69.1%
2012 -NZ$38.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$17.10 B-2,258.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$43.17 B-5,549.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$16.60 B-2,195.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-NZ$0.24 Billion-70.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$1.57 B-299.35%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.80 B-202.19%๐Ÿ‡บ๐Ÿ‡ธ USA